|
Therapy area
Episodic treatment of recurrent labial herpes based on a combination concept.
|
|
In phase
Phase III program was completed in December 2007 and the results reported in March 2008. |
Competitive edge
The first treatment with substantial efficacy against recurrent labial herpes - expected to prevent occurrence of cold sores with early treatment onset. |
Project data
- First treatment of recurrent labial herpes with potential to prevent lesion development
- Low risk for adverse events
- Genital herpes is a potential second indication
|
Main products 2006
Acyclovir GlaxoSmithKline
Valaciclovir GlaxoSmithKline
Famciclovir Novartis
Updated: 03/04/2008
|
